Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare

Overview

Journal Clin J Am Soc Nephrol

Specialty Nephrology

Date 2015 Dec 25

PMID 26700439

Citations 26

Authors

Daniel J Birmingham

Joshua E Bitter

Ezinne G Ndukwe

Sarah Dials

Terese R Gullo

Sara Conroy

Haikady N Nagaraja

Brad H Rovin

Lee A Hebert

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Autoantibodies to complement C1q (anti-C1q) are associated with the diagnosis of lupus nephritis. In this study, we compare anti-C1q IgG with another complement autoantibody, anti-C3b IgG, as a biomarker of lupus nephritis and lupus nephritis flare.

Design, Setting, Participants, & Measurements: Our investigation involved the Ohio SLE Study, a prospective observational cohort of patients with recurrently active lupus who were followed bimonthly. Serum anti-C1q and anti-C3b IgG levels were assessed cross-sectionally by ELISA in 40 normal controls and 114 patients in the Ohio SLE Study (41 nonrenal and 73 lupus nephritis) at study entry, and longitudinally in a subset of patients in the Ohio SLE Study with anti-C1q-positive lupus nephritis in samples collected every 2 months for 8 months leading up to lupus nephritis flare (n=16 patients).

Results: In the cross-sectional analysis, compared with anti-C1q IgG, anti-C3b IgG was less sensitive (36% versus 63%) but more specific (98% versus 71%) for lupus nephritis. Only anti-C3b IgG was associated with patients with lupus nephritis who experienced at least one lupus nephritis flare during the Ohio SLE Study period (P<0.01). In the longitudinal analysis, circulating levels of anti-C1q IgG increased at the time of lupus nephritis flare only in patients who were anti-C3b positive (P=0.02), with significant increases occurring from 6 (38% increase) and 4 months (41% increase) before flare. Anti-C3b IgG levels also trended up at lupus nephritis flare, although the change did not reach statistical significance (P=0.07). Neither autoantibody increased 2 months before flare.

Conclusions: Although not as prevalent as anti-C1q IgG, anti-C3b IgG showed nearly complete specificity for lupus nephritis. The presence of anti-C3b IgG identified patients with lupus nephritis who were prone to flare and in whom serial measurements of markers associated with complement, such as anti-C1q IgG, may be useful to monitor lupus nephritis activity.

Citing Articles

Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review.

Calatroni M, Moroni G, Conte E, Stella M, Reggiani F, Ponticelli C Front Immunol. 2024; 15:1410032.

PMID: 38938561 PMC: 11208682. DOI: 10.3389/fimmu.2024.1410032.

Silent Storm Unveiled: Lupus Nephritis and Cerebral Vasculitis in Systemic Lupus Erythematosus.

Sawant R, Gaidhane S, Mahajan V, Chaudhari P, Bedi G Cureus. 2024; 16(4):e57751.

PMID: 38716007 PMC: 11074806. DOI: 10.7759/cureus.57751.

Clinical Relevance of Anti-C3 and Anti-C4 Autoantibodies in Lupus Nephritis.

Vasilev V, Artero M, Petkova M, Mihaylova G, Dragon-Durey M, Radanova M Kidney Int Rep. 2024; 9(5):1429-1440.

PMID: 38707805 PMC: 11068950. DOI: 10.1016/j.ekir.2024.01.052.

Lupus Nephritis Biomarkers: A Critical Review.

Alduraibi F, Tsokos G Int J Mol Sci. 2024; 25(2).

PMID: 38255879 PMC: 10815779. DOI: 10.3390/ijms25020805.

Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Almaani S, Song H, Suthanthira M, Toy C, Fussner L, Meara A Kidney Int Rep. 2023; 8(11):2421-2427.

PMID: 38025219 PMC: 10658281. DOI: 10.1016/j.ekir.2023.08.017.

References

Kohro-Kawata J, Wener M, Mannik M . The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus. J Rheumatol. 2002; 29(1):84-9. View

Vanhecke D, Roumenina L, Wan H, Osthoff M, Schaller M, Trendelenburg M . Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay. Arthritis Rheum. 2012; 64(11):3706-14. DOI: 10.1002/art.34605. View

Trouw L, Groeneveld T, Seelen M, Duijs J, Bajema I, Prins F . Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest. 2004; 114(5):679-88. PMC: 514584. DOI: 10.1172/JCI21075. View

LACHMANN P . Conglutinin and immunoconglutinins. Adv Immunol. 1967; 6:479-527. DOI: 10.1016/s0065-2776(08)60527-1. View

Isenman D, Cooper N . The structure and function of the third component of human complement--I. The nature and extent of conformational changes accompanying C3 activation. Mol Immunol. 1981; 18(4):331-9. DOI: 10.1016/0161-5890(81)90057-2. View

Durand C, Burge J . A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement. Findings in systemic lupus erythematosus. J Immunol Methods. 1984; 73(1):57-66. DOI: 10.1016/0022-1759(84)90031-0. View

Antes U, Heinz H, Loos M . Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum. 1988; 31(4):457-64. DOI: 10.1002/art.1780310401. View

Alsenz J, Becherer J, Nilsson B, Lambris J . Structural and functional analysis of C3 using monoclonal antibodies. Curr Top Microbiol Immunol. 1990; 153:235-48. DOI: 10.1007/978-3-642-74977-3_13. View

Nilsson B, Ekdahl K, Svarvare M, Bjelle A, Nilsson U . Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function. Clin Exp Immunol. 1990; 82(2):262-7. PMC: 1535126. DOI: 10.1111/j.1365-2249.1990.tb05437.x. View

10.

Siegert C, Daha M, Westedt M, van der Voort E, Breedveld F . IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol. 1991; 18(2):230-4. View

11.

Wisnieski J, Jones S . Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol. 1992; 148(5):1396-403. View

12.

Nilsson B, Ekdahl K, Sjoholm A, Nilsson U, Sturfelt G . Detection and characterization of immunoconglutinins in patients with systemic lupus erythematosus (SLE): serial analysis in relation to disease course. Clin Exp Immunol. 1992; 90(2):251-5. PMC: 1554629. DOI: 10.1111/j.1365-2249.1992.tb07937.x. View

13.

Mannik M, Wener M . Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 1997; 40(8):1504-11. DOI: 10.1002/art.1780400819. View

14.

Rovin B, Song H, Birmingham D, Hebert L, Yu C, Nagaraja H . Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol. 2004; 16(2):467-73. DOI: 10.1681/ASN.2004080658. View

15.

Seelen M, Roos A, Wieslander J, Mollnes T, Sjoholm A, Wurzner R . Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods. 2005; 296(1-2):187-98. DOI: 10.1016/j.jim.2004.11.016. View

16.

Rovin B, Tang Y, Sun J, Nagaraja H, Hackshaw K, Gray L . Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int. 2005; 68(2):747-59. DOI: 10.1111/j.1523-1755.2005.00453.x. View

17.

Birmingham D, Nagaraja H, Rovin B, Spetie L, Zhao Y, Li X . Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele. Arthritis Rheum. 2006; 54(10):3291-9. DOI: 10.1002/art.22135. View

18.

Sinico R, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G . Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci. 2009; 1173:47-51. DOI: 10.1111/j.1749-6632.2009.04746.x. View

19.

Birmingham D, Irshaid F, Nagaraja H, Zou X, Tsao B, Wu H . The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus. 2010; 19(11):1272-80. PMC: 3086056. DOI: 10.1177/0961203310371154. View

20.

Kenyon K, Cole C, Crawford F, Kappler J, Thurman J, Bratton D . IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity. J Immunol. 2011; 187(5):2101-11. PMC: 3159788. DOI: 10.4049/jimmunol.1003468. View